STN-DBS: The Effect of Deep Brain Stimulation on Facial Expressions.

Sponsor
Mustafa Kemal University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03558568
Collaborator
(none)
18
1
5
19
0.9

Study Details

Study Description

Brief Summary

Whether Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS), a treatment commonly used to ameliorate the motor symptoms of Parkinson's disease (PD), affects on facial expressions is unclear. The purpose of this study was to investigate the potential effects of DBS and different frequencies on facial expressions of PD patients by volunteers via a web site: http://www.supporttoscience.com

Condition or Disease Intervention/Treatment Phase
  • Device: Deep Brain Stimulation
N/A

Detailed Description

Parkinson's disease (PD) is the second most frequent progressive neuro-degenerative disease with a worldwide prevalence of 4-6 million and the mask face is an important and also troublesome sign of PD. Deep Brain Stimulation (DBS) surgery can be a viable option which has recently emerged and been accepted as a useful surgical method for PD. Standard DBS targets include Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi). Although the STN-DBS application is known to have favorable effects on motor and non-motor symptoms of PD, there is a lack information about the effect on facial expressions of PD patients. Our aim is to analyze the effect of the STN-DBS stimulation and different frequencies on the facial expressions of PD patients.

The study initially recruited 18 patients with idiopathic PD who underwent DBS surgery for movement disorders caused by PD at Mustafa Kemal University Medical Faculty Neurosurgery Department.

Inclusion criteria:
  • Idiopathic PD responsive to L-Dopa treatment,

  • Between 40-75 years of age,

  • Having received bilateral STN DBS surgery at least six months prior to the investigation to ensure stable stimulation parameters,

  • Mentally normal patients that could understand and respond to a directives. The evaluation will be made by the face photos of the patients. The face photos for the expressions including [normal], [sad], [happy], and [angry] were obtained at frequencies including 130 Hz, 60 Hz, 99 Hz, 230 Hz and off-stimulation. The face photos will evaluate by the software and by the volunteers with the aim of a website: http://www.supporttoscience.com

Study Design

Study Type:
Interventional
Anticipated Enrollment :
18 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study initially recruited 18 patients with idiopathic PD who underwent DBS surgery for movement disorders caused by PD at Mustafa Kemal University Medical Faculty Neurosurgery Department. Inclusion criteria: Idiopathic PD responsive to L-Dopa treatment, Between 40-75 years of age, Having received bilateral STN DBS surgery at least six months prior to the investigation to ensure stable stimulation parameters, Mentally normal patients that could understand and respond to a directives.The study initially recruited 18 patients with idiopathic PD who underwent DBS surgery for movement disorders caused by PD at Mustafa Kemal University Medical Faculty Neurosurgery Department.Inclusion criteria:Idiopathic PD responsive to L-Dopa treatment, Between 40-75 years of age, Having received bilateral STN DBS surgery at least six months prior to the investigation to ensure stable stimulation parameters, Mentally normal patients that could understand and respond to a directives.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
The Effect of Subthalamic Nucleus Deep Brain Stimulation on Facial Expressions in Parkinson's Disease.
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Aug 12, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: DBS off

Device: Deep Brain Stimulation
Deep Brain Stimulation is an established surgical method for Parkinson's Disease.
Other Names:
  • Vercise
  • Activa PC
  • Active Comparator: DBS on 60 Hz.

    Device: Deep Brain Stimulation
    Deep Brain Stimulation is an established surgical method for Parkinson's Disease.
    Other Names:
  • Vercise
  • Activa PC
  • Active Comparator: DBS on 99 Hz.

    Device: Deep Brain Stimulation
    Deep Brain Stimulation is an established surgical method for Parkinson's Disease.
    Other Names:
  • Vercise
  • Activa PC
  • Active Comparator: DBS on 130 Hz.

    Device: Deep Brain Stimulation
    Deep Brain Stimulation is an established surgical method for Parkinson's Disease.
    Other Names:
  • Vercise
  • Activa PC
  • Active Comparator: DBS on 230 Hz.

    Device: Deep Brain Stimulation
    Deep Brain Stimulation is an established surgical method for Parkinson's Disease.
    Other Names:
  • Vercise
  • Activa PC
  • Outcome Measures

    Primary Outcome Measures

    1. The effect of Deep brain stimulation on facial expressions will be analyzed by volunteers via a web site then the results will evaluate by statistical analyses. [3 months]

      The evaluation of patients photos (in different frequencies and when stimulation off status) will be analyzed by volunteers via a website, then the results will be compare and evaluate by statistical analysis. The results will give us an opinion about these: The effect of Deep Brain Stimulation on Parkinsonians patients facial expression and which frequency setting is better for facial expression.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Idiopathic PD responsive to L-Dopa treatment,

    • Between 40-75 years of age,

    • Having received bilateral STN DBS surgery at least one month prior to the investigation to ensure stable stimulation parameters,

    • Mentally normal patients that could understand and respond to a questionnaire.

    Exclusion Criteria:
    • Above 75 years of age,

    • Severe dementia,

    • History of an additional neurologic disease,

    • The presence of a disease, such as the facial paralysis, that could affect facial expressions,

    • Having a wound on the face.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Atilla YILMAZ Hatay Turkey 31070

    Sponsors and Collaborators

    • Mustafa Kemal University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Atilla YILMAZ, Assistant Professor, Mustafa Kemal University
    ClinicalTrials.gov Identifier:
    NCT03558568
    Other Study ID Numbers:
    • 1
    First Posted:
    Jun 15, 2018
    Last Update Posted:
    Mar 14, 2019
    Last Verified:
    Mar 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Atilla YILMAZ, Assistant Professor, Mustafa Kemal University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 14, 2019